A Charles Fischer Net Worth

The estimated Net Worth of A Charles Fischer is at least $275 mil dollars as of 6 November 2013. A Fischer owns over 13,500 units of Neogen stock worth over $274,500 and over the last 17 years A sold NEOG stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

A Fischer NEOG stock SEC Form 4 insiders trading

A has made over 5 trades of the Neogen stock since 2011, according to the Form 4 filled with the SEC. Most recently A exercised 13,500 units of NEOG stock worth $160,785 on 6 November 2013.

The largest trade A's ever made was exercising 13,500 units of Neogen stock on 6 November 2013 worth over $160,785. On average, A trades about 1,850 units every 55 days since 2007. As of 6 November 2013 A still owns at least 18,000 units of Neogen stock.

You can see the complete history of A Fischer stock trades at the bottom of the page.

What's A Fischer's mailing address?

A's mailing address filed with the SEC is 4904 WARBLERS WAY, , MIDLAND, MI, 48640.

Insiders trading at Neogen

Over the last 24 years, insiders at Neogen have traded over $135,917,555 worth of Neogen stock and bought 195,554 units worth $4,379,833 . The most active insiders traders include James L Herbert, Jeffrey D Capello y Lon M Bohannon. On average, Neogen executives and independent directors trade stock every 11 days with the average trade being worth of $140,346. The most recent stock trade was executed by Ronald D Green on 29 August 2024, trading 4,446 units of NEOG stock currently worth $68,780.

What does Neogen do?

neogen corporation develops and markets products dedicated to food and animal safety. the company’s food safety division markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. neogen’s animal safety division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants and rodenticides.

Complete history of A Fischer stock trades at Neogen

Neogen executives and stock owners

Neogen executives and other stock owners filed with the SEC include:

• John Adent,
  President, Chief Executive Officer, Director
• Steven Quinlan,
  Chief Financial Officer, Vice President, Secretary
• John Edward Adent,
  Pres, CEO & Director
• Jason Lilly,
  Vice President - International Business
• Jerome Hagedorn,
  Vice President - Food Safety operations
• Douglas E. Jones,
  VP & Chief Commercial Officer
• Steven J. Quinlan,
  VP & CFO
• James Borel,
  Lead Independent Chairman of the Board
• James Tobin,
  Independent Director
• Ronald Green,
  Independent Director
• William Boehm,
  Independent Director
• Darci Vetter,
  Independent Director
• G. Bruce Papesh,
  Independent Director
• Doug Jones,
  Chief Commercial Officer
• Amy M. Rocklin Ph.D.,
  VP, Gen. Counsel & Corp. Sec.
• Julie A. Mann,
  VP & Chief HR Officer
• Rod Poland,
  Director of Corp. Communications
• Amy Rocklin Ph.D.,
  VP & Gen. Counsel
• Sarah Demey,
  Admin. Mang.
• Bruce Papesh,
  Director
• A Charles Fischer,
  Director
• Richard E Jr Calk,
  President & COO
• Richard T Crowder,
  Director
• Jack C Parnell,
  Director
• Clayton K Yeutter,
  Director
• Thomas H Reed,
  Director
• Terri A Morrical,
  
• David H. Naemura,
  Chief Financial Officer
• Edward Bradley,
  V.P. Sales and Marketing
• Aashima Gupta,
  Director
• Jeffrey D Capello,
  Director
• Rex L Hamilton,
  Vice President
• Herbert D Doan,
  Director
• Gordon E Guyer,
  Director
• James L Herbert,
  Director
• Joseph M Madden,
  V.P. Scientific Affairs
• Richard R Current,
  Vice President & CFO
• Anthony E Maltese,
  VP Business Development
• Kenneth V Kodilla,
  Vice President
• Lon M Bohannon,
  COO
• Mark A Mozola,
  Vice President of R&D
• Leonard E Heller,
  Director
• Robert M Book,
  Director
• Stephen K. Snyder,
  Former Pres. and COO
• Paul S Satoh,
  V.P Research and Development
• Rafael A Rodriguez,
  Director
• Catherine E Woteki,
  Director
• Amy M Rocklin,
  Chief Legal Officer
• John Patrick Moylan,
  Chief Accounting Officer